The high intensity focused ultrasound therapy market size is expected to grow from US$ 505.49 million in 2024 to US$ 879.87 million by 2031; it is projected to register a CAGR of 8.3% during 2025-2031. The rising prevalence of chronic diseases and cancer, and soaring preference for noninvasive procedures are noteworthy factors contributing to the expansion of the high intensity focused ultrasound therapy market size. Additionally, the integration with artificial intelligence for enhanced precision is projected to bring new high intensity focused ultrasound therapy market trends in the near future.

One of the main advantages of HIFU therapy is the use of robotic technologies that allow for precise control and the ability to make changes in real-time during the operations. These systems with the help of robotics reach submillimeter accuracy, get the images in the real time, and make the modifications automatically, thus they solve the problems which are the limitations of the manual operations, such as the inconsistency of the targeting and the fatigue of the operator. The Focal One Robotic HIFU System is the FDA cleared device for the treatment of prostate cancer by focal therapy. High-resolution transrectal ultrasound imaging is combined with a robotized probe having five degrees of freedom by this platform. It makes a 3D model of the prostate, thus enabling the urologists to do the ablation both the planning as well as the execution with the dynamic focusing-a precise energy delivery in each 5mm increment up to 40mm in depth. By using Focal One to treat local tumors is fast (less than an hour) and can be done as a day hospital surgery at the VCU Massey Cancer Center. Besides, the healthy tissue is spared, and the urinary/sexual functions are preserved. The studies show that there is more than 90% retention of the continence after the therapy, which is in stark contrast to the 10-20% risk of incontinence considered radical prostatectomy. FUTURA is a robotic European-funded platform for computer-assisted HIFU delivery, which through multi-axis manipulators positions extracorporeal transducers and thereby is a perfect solution for liver cancer ablation. Tissue motion is adjusted for through the real-time feedback loops of FUTURA, which in fact uniform lesion formation has been achieved in preclinical trials, off-target heating has been reduced by 30%.

The next generations may have AI, which will be able to predict the targeting, making pancreatic and breast cancers as the new applications. In the end, robotic-assisted HIFU is the way to a bright future when the precise, non-invasive care, with the minimal side effects and the quick recovery, will be available to everybody in the era of personalized medicine and are expected to emerge as a significant trend in the high intensity focused ultrasound therapy market.

End User-Based Insights

Based on end user, the high intensity focused ultrasound therapy market is segmented into healthcare facilities, diagnostic imaging centers, and research centers. The healthcare facilities segment held the largest high intensity focused ultrasound therapy market share in 2024. With the help of its strong infrastructure, specialized clinical knowledge, and ability to incorporate advanced non-invasive technologies into standard patient care, healthcare facilities have been leading the end-user market of the global High-Intensity Focused Ultrasound (HIFU) therapy market for a considerable time. The main impetus to the growth of the industry is constituted of the increasing prevalence of chronic diseases such as prostate cancer, uterine fibroids, and neurological disorders like essential tremor, for which HIFU is the method of choice to offer precise tumor ablation with minimal invasiveness, less recovery time, and a smaller number of side effects in comparison to the traditional surgery. The hospital's capability to manage complex cases efficiently is what is letting them to be quickly embraced technologically as hospitals, they get implemented there, and it is further accelerated by technological innovations including real-time MRI-guided systems, AI-enhanced precision targeting, and robotic integration that improve treatment accuracy and safety.

As older populations dictate the need for more outpatient-like procedures, hospitals have started investing in training programs and hybrid operating suites, thus enabling device innovators to establish collaborative networks. The growth of this segment is also supported by the transition to ambulatory care after the pandemic, where the outpatient feasibility of HIFU leads to fewer infection risks and less operational burdens, thereby fueling the high intensity focused ultrasound therapy market growth.

The World Health Organization, the Pan American Health Organization, and Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the high intensity focused ultrasound therapy market report.